Logotype for Inogen Inc

Inogen (INGN) Q3 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Inogen Inc

Q3 2026 earnings summary

9 Nov, 2026

Executive summary

  • Q3 continuing-operations revenue was $77.193M, down 2.4% YoY; adjusted net loss was $0.4M versus adjusted earnings of $1.2M a year earlier.

  • U.S. sales returned to YoY growth for the first time since Q4 2024, while lower international sales offset the increase.

  • Andy Reding became President and CEO; priorities include commercial execution, growth products, and disciplined costs.

  • The U.S. oxygen rental business was sold after quarter-end, with a post-sale program targeting $20M in annualized savings by end-2027.

Financial highlights

  • Q3 revenue was $77.193M versus $79.090M a year earlier; constant-currency revenue declined 3.2%.

  • GAAP loss from continuing operations was $14.794M versus $3.6M in Q3 2025, including a $10.559M non-cash goodwill impairment.

  • Adjusted diluted loss per share was $0.02 versus adjusted earnings per share of $0.04; adjusted operating loss was $1.2M versus $0.6M.

  • Nine-month revenue rose 2.8% to $233.122M; GAAP loss from continuing operations was $25.4M and adjusted loss was $2.9M.

  • Q3 operating cash flow was negative $4.5M due to higher working capital; nine-month continuing-operations cash used was $13.610M, improved from $20.398M.

Outlook and guidance

  • Q4 2026 continuing-operations revenue guidance is $65M-$68M; FY 2026 guidance is $298M-$301M.

  • FY 2026 adjusted loss from continuing operations is expected to be $7M-$8M; adjusted net earnings replaces adjusted EBITDA after the divestiture.

  • International softness is expected to continue into Q4, with U.S. growth projected to accelerate and offset some weakness.

  • Savings program targets ~$20M annualized, with about half expected in Q4 2026 and the balance during 2027; substantial completion is expected by end-2027.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Inogen